维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="WILDER RB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Treatment of unicentric and multicentric Castleman disease and the role of readiotherapy显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
2	Radiotherapy alone for lymphocyte-predominant Hodgkin' s disease 显示文摘	Schlembach PJ Wilder RB Jones D	2002	Cancer J2002，8，5：	1
3	An elevated serum beta- 2 microglobulin level is an adverse prognostic factor for overall survival in patients with early - stage Hodgkin disease 显示文摘	Chronowski GM Wilder RB Tucker SL	2002	Cancer2002，95，：	1
4	European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de 1' Adulte very favorable and favorable, lympho- cyte-predominant Hodgkin disease 显示文摘	Wilder RB Schlembach P J Jones D	2002	Cancer2002，94，6：	1
5	Radioimmunotherapy recent results and future direction显示文摘	Wilder RB Denardo GL Denard SJ	1996	J Clin Oncol1996，14，4：	1
6	Treatment of unieentric and multicentric Castleman disease and the role of radiotherapy 显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
7	Pterygium treated with excision and postoperative beta irradiation显示文摘	Wilder RB Ruatti JM Kittelson JM	1992	Int J Radiat Oncol Biol Phys1992，23，5：	1
8	Results with accelerated partial breast irradiation in terms of estrogen receptor,progesterone receptor,and human growth factor receptor 2 status显示文摘	Wilder RB Curcio LD Khanijou RK	2010	Int J Radiat Oncol Biol Phys2010，78，3：	1
9	Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
10	Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans显示文摘	Kubo HD Wilder RB Pappas CTE	1999	Int J Radiat Oncol Biol Phys1999，44，：	1
11	Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma显示文摘	Wilder RB Rodriguez MA Ha CS		0，，：	1
12	Impact of involved field radiotherapy after CHOP-based chemotherapy on stage l~ - IV, intermediate grade and large-cell immunoblastie lymphomas 显示文摘	Schlembach PJ Wilder RB Tucker SL	2000	Int J Radiat Oncol Biol Phys2000，48，4：	1
13	Clinical stage IEA-IIEA orbital lymphomas:Outcomes in the era of modern staong and treatment显示文摘	Pelloski CE Wilder RB Ha CS	2001	Radither Oncol2001，59，2：	1
14	Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas 显示文摘	Wilder RB Jones D	2002	Leu Lymphoma2002，43，9：	1
15	Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
16	Treatment ofunicentric and multicentric Castleman disease and the role of radiotherapy显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，：	1
17	Treatment of unicentric and muhicentric Castleman disease and the role of radiotherapy 显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
18	Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
19	Treatment of unicentric and multicentric castleman disease and the role of radiotherapy显示文摘	Chronowski GM Ha CS Wilder RB	2001	Cancer2001，92，3：	1
20	Ra- diotherapy Treatment Planning for Testiculai' Seminoma显示文摘	Wilder RB Buyyounouski MK Efstathiou JA	2012	Int J Radiat Oncol Biol Phys2012，83，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示